Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Aristea Therapeutics, Inc.
Age
18–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At least 6 months history of moderate or severe PPP, as defined by PPPASI ≥12 and PPPGA ≥3 at screening
Males and females must be willing to use birth control as indicated
You may not be if
Moderate to severe psoriasis covering ≥10% of total body surface area (BSA) at screening
Breastfeeding or pregnant
Known immunodeficiency or subject is immunocompromised
Active/latent infection with HBV, HCV, HIV, SARS-CoV-2 or TB
Any topical medications for PPP excluding emollients within two weeks of randomization and systemic therapies (including phototherapy) within 4 weeks of randomization
Clareo Health | A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
